• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Elliot on ROBUST III trial of Optilume drug-coated balloon for anterior urethral strictures


In this video, Sean P. Elliott, MD, MS, FACS, discusses the abstract, “Interim results for the ROBUST III trial evaluating the Optilume drug-coated balloon for anterior urethral strictures,” which was presented during the 2021 American Urological Association annual meeting. Elliott is a professor, vice chair of urology, and director of reconstructive urology at the University of Minnesota, Minneapolis.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.